• Centers and Departments
• Back to Divisions
• Cardiovascular Medicine
• About Us
• Programs and Services
• Meet Our Team
• For Referring Physicians
• For Patients
• Make an Appointment
• Diseases and Conditions
• Your Heart Health
• Clinical Trials
  • Coronary Artery Disease with Diabetes
  • Coronary Artery Disease with Excess Weight
  • Heart Attack
  • Patent Foramen Ovale
  • Percutaneous Coronary Intervention
  • Renal Atery Stenosis
• Patient Stories
• Media Gallery
• Research
• Medical Education

Heart Attack

ICE-T Trial

A Randomized Trial Evaluating Low-Dose IntraCoronary AdjunctivE Tenecteplase During Primary PCI for ST-Elevation Myocardial Infarction

Principal Investigator

Duane S. Pinto, MD

Co-Investigators

Donald E. Cutlip, MD
C. Michael Gibson, MD
Kalon Ho, MD
Roger J. Laham, MD
David E. Leeman, MD
Samuel J. Shubrooks, Jr., MD

Coordinator

Paula Rooney, RN
Phone: 617-632-7484
Email: prooney@bidmc.harvard.edu

Focus: Patients with ST-segment elevation myocardial infarction

The ICE-T trial is gathering preliminary data regarding the angiographic effectiveness of the administration of low-dose Intracoronary (IC) Tenecteplase (a clot buster) during preliminary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).